121 related articles for article (PubMed ID: 18158567)
1. Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas.
Yuan A; Liu J; Liu Y; Cui G
Pathol Oncol Res; 2007; 13(4):321-5. PubMed ID: 18158567
[TBL] [Abstract][Full Text] [Related]
2. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.
Ku JW; Zhang DY; Song X; Li XM; Zhao XK; Lv S; Hu SJ; Cheng R; Zhou FY; Wu HF; Wang LD
Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575250
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin-A expression in gastric and colon cancer tissues.
Park JG; Choe GY; Helman LJ; Gazdar AF; Yang HK; Kim JP; Park SH; Kim YI
Int J Cancer; 1992 May; 51(2):189-94. PubMed ID: 1349007
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in bronchial carcinomas of classic squamous-cell type: an immunohistochemical study of 29 cases applying the tyramide signal amplification technique.
Fresvig A; Qvigstad G; Halvorsen TB; Falkmer S; Waldum HL
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):9-13. PubMed ID: 11277422
[TBL] [Abstract][Full Text] [Related]
5. Use of neuroendocrine serum markers in the follow-up of patients with cancer of the prostate.
Angelsen A; Syversen U; Stridsberg M; Haugen OA; Mjølnerød OK; Waldum HL
Prostate; 1997 May; 31(2):110-7. PubMed ID: 9140124
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
[TBL] [Abstract][Full Text] [Related]
7. Characterization of scattered neuroendocrine cells in ductal carcinoma of the pancreas.
Tezel E; Nagasaka T; Tezel G; Nakao A
Pancreas; 2002 Aug; 25(2):136-41. PubMed ID: 12142735
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
9. Expression of midkine and its clinical significance in esophageal squamous cell carcinoma.
Ren YJ; Zhang QY
World J Gastroenterol; 2006 Apr; 12(13):2006-10. PubMed ID: 16610048
[TBL] [Abstract][Full Text] [Related]
10. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
12. Expression of neuroendocrine markers in non-small cell lung cancer.
Sørhaug S; Steinshamn S; Haaverstad R; Nordrum IS; Martinsen TC; Waldum HL
APMIS; 2007 Feb; 115(2):152-63. PubMed ID: 17295682
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin.
Xing N; Qian J; Bostwick D; Bergstralh E; Young CY
Prostate; 2001 Jun; 48(1):7-15. PubMed ID: 11391682
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
Deng F; Zhou K; Cui W; Liu D; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
[TBL] [Abstract][Full Text] [Related]
15. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG
Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200
[TBL] [Abstract][Full Text] [Related]
16. Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications.
Li SP; Guan QL; Zhao D; Pei GJ; Su HX; Du LN; He JX; Liu ZC
Med Sci Monit; 2016 May; 22():1654-62. PubMed ID: 27184872
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine differentiation in stage D2 prostate cancers.
Kamiya N; Suzuki H; Kawamura K; Imamoto T; Naya Y; Tochigi N; Kakuta Y; Yamaguchi K; Ishikura H; Ichikawa T
Int J Urol; 2008 May; 15(5):423-8. PubMed ID: 18452460
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma].
Xue LY; Ren LQ; Luo W; Guan XJ; Zou SM; Zheng S; Bi R; Xie YQ; He ZG; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):150-4. PubMed ID: 17425843
[TBL] [Abstract][Full Text] [Related]
20. Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.
Sun YL; Liu F; Liu F; Zhao XH
World J Gastroenterol; 2016 Aug; 22(32):7322-31. PubMed ID: 27621578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
